Improved Therapeutic Effect of Puerarin-Encapsulated PEG-PLGA Nanoparticle on an In Vitro Cerebral Infarction Model

Improved Therapeutic Effect of Puerarin-Encapsulated PEG-PLGA Nanoparticle on an In Vitro Cerebral Infarction Model

This study was to explore the therapeutic effect and mechanism of puerarin (PUE) combined with PEGylated nanoparticles on a rat cerebral infarction cell model. In this context, PEG-PLGA/PUE nanoparticles were prepared by the thin-film hydration method, and the toxicity of PEG-PLGA/PUE nanoparticles...

Full description

Bibliographic Details
Main Authors:	Lei Li, Yan Li, Cheng Miao, Rui Liu
Format:	Article
Language:	English
Published:	Hindawi-Wiley 2020-01-01
Series:	Advances in Polymer Technology
Online Access:	http://dx.doi.org/10.1155/2020/7145738

Similar Items

Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
by: Li Tang, et al.
Published: (2012-01-01)

Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
by: Sanyuan Hu, et al.
Published: (2010-11-01)

PLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro
by: Hung, Hsin-I, et al.
Published: (2017)

Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity
by: Blerina Shkodra-Pula, et al.
Published: (2020-05-01)

Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells
by: Bokai Zhang, et al.
Published: (2017-08-01)

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
by: Rafiei P, et al.
Published: (2017-01-01)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
by: György Babos, et al.
Published: (2018-08-01)

Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib
by: Ning Zheng, et al.
Published: (2019-05-01)

Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
by: Duan D, et al.
Published: (2018-03-01)

Influence of PLGA and PLGA-PEG on the dissolution profile of oxaliplatin
by: Emiliane Daher Pereira, et al.

Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content
by: Avgoustakis K, et al.
Published: (2012-03-01)

Puerarin Attenuates Cerebral Damage by Improving Cerebral Microcirculation in Spontaneously Hypertensive Rats
by: Xu-Dong Wu, et al.
Published: (2014-01-01)

Neuroprotective effect of insulin-loaded chitosan nanoparticles/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats
by: Rong X, et al.
Published: (2018-12-01)

Antioxidant Effects of Quercetin and Catechin Encapsulated into PLGA Nanoparticles
by: Hector Pool, et al.
Published: (2012-01-01)

Fabrication and in vitro Evaluation of 4-HIA Encapsulated PLGA Nanoparticles on PC12 Cells
by: Ravikiran T, et al.
Published: (2021-08-01)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
by: Bao W, et al.
Published: (2019-04-01)

Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats
by: Chang Yi, et al.
Published: (2009-01-01)

Assessment of the Effect of PLGA Co-polymers and PEG on the Formation and Characteristics of PLGA-PEG-PLGA Co-block Polymer Using Statistical Approach
by: Teuku Nanda Saifullah Sulaiman, et al.
Published: (2019-08-01)

Studies of PEG/PLGA/PEG Based Drug Delivery System
by: A-Chuan Liao, et al.
Published: (2004)

STUDIES ON THE SYNTHESIS AND PROPERTIES OF THERMOSENSITIVE PLGA-PEG-PLGA TRIBLOCK COPOLYMERS
by: Chung-Fu Yu, et al.
Published: (2009)

Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
by: Zulaikha A. Busari, et al.
Published: (2017-09-01)

Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells
by: Liu P, et al.
Published: (2016-08-01)

Synthesis and Characterizations of Folate-Conjugated PLGA-PEG Nanoparticles Loaded with Dual Agents
by: Yüksel Öğünç, et al.
Published: (2017-11-01)

Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles.
by: Kai Zhao, et al.
Published: (2013-01-01)

Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
by: Wenqun Li, et al.
Published: (2018-01-01)

Synthesis, Characterization, and Biological Evaluation of Anti-HER2 Indocyanine Green-Encapsulated PEG-Coated PLGA Nanoparticles for Targeted Phototherapy of Breast Cancer Cells.
by: Yu-Hsiang Lee, et al.
Published: (2016-01-01)

The effect of PLGA-PEG-PLGA modification on the sol-gel transition and degradation properties
by: J. Oborna, et al.
Published: (2016-05-01)

Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease
by: Shengnuo Fan, et al.
Published: (2018-01-01)

Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: In Vitro characterization as an effective aerosol formulation in pulmonary diseases
by: Pirooznia Nazanin, et al.
Published: (2012-05-01)

Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR–Cas9 plasmid
by: Ami Jo, et al.
Published: (2020-01-01)

Enhancement of Oral Bioavailability of Puerarin by Polybutylcyanoacrylate Nanoparticles
by: Lixia Zhao, et al.
Published: (2011-01-01)

Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles
by: Luo CF, et al.
Published: (2013-03-01)

Gentamicin Sulfate PEG-PLGA/PLGA-H Nanoparticles: Screening Design and Antimicrobial Effect Evaluation toward Clinic Bacterial Isolates
by: Rossella Dorati, et al.
Published: (2018-01-01)

Evaluation of the effect of crocetin on antitumor activity of doxorubicin encapsulated in PLGA nanoparticles
by: F. A Langroodi, et al.
Published: (2016-01-01)

Nanoparticles Of PLGA With Encapsulated Insulin For Oral Controlled Release For Diabetes Treatment
by: Abduljawad, Marwan
Published: (2015)

PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency
by: Fei Yu, et al.
Published: (2017-01-01)

Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma
by: Liu XJ, et al.
Published: (2017-07-01)

Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets
by: Rana Bakhaidar, et al.
Published: (2019-10-01)

Novel Mannan-PEG-PE Modified Bioadhesive PLGA Nanoparticles for Targeted Gene Delivery
by: Guicun Wu, et al.
Published: (2012-01-01)

Synthesis and Characterization of Aspartic acid-Modify PLGA-g-PEG Nanoparticles for Bone Targeting
by: Hung-Jen Wang, et al.
Published: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hh1brbh8940jian8pchbaqhhjg